NSCMID 2024 Meeting Scientific Programme

OSLO NORWAY  Aug. 29 - Sept. 1 2024.

 

Thursday 29. August

09:00 – 12:30 Registration open
08:30- 11:30 Board meeting NSCMID
10.30 – 11.30 Annual meetings NFIM & NFMM
NFIM (Norwegian Society of Infectious Diseases): in the conference hall
NFMM (Norwegian Society of Medical Microbiology): in the board room (Federation Square)

11.30 – 12.30 Lunch at the exibition

12:30-12:40 Opening of NSCMID 2024

 

Symposium 1

12:40 – 13.40 State of the art – endocarditis
Chairs: Jan Erik Berdal, Lørenskog, Norway and Torgunn Væhre, Oslo, Norway

New guidelines – an update, Magnus Rasmussen, Lund, Sweden 

 

13.40 – 13.50 Short break

 

Symposium 2
13:50 – 15:05 Respiratory infections
Chairs: Jan Erik Berdal Lørenskog, Norway and Truls Leegaard, Lørenoskog, Norway 

Lower airway infections – hot topics and controversies, Lars Heggelund, Drammen/Bergen, Norway 
Current diagnostics, Siri Knoop, Bergen, Norway

Imaging and CAP, Christian Backer Mogensen, Odense, Denmark

 

15.05 – 15.35 Coffee in the exibition

 

Symposium 3
15:35 – 16:50  Respiratory infections  – clinical cases
Chairs: Jan Erik Berdal Lørenskog, Norway and Truls Leegaard Lørenskog, Norway

X-ray pos vs x-ray neg CAP, Magnús Gottfreðsson, Reykjavik, Iceland

A retrospective study on the impact of antibiotic therapy on mortality in viral respiratory infections, Magrit Hovind, Lørenskog, Norway

Time to stop treating viral respiratory infections with antibiotics ? Rationale and design for ATHENIAN a pragmatic multicenter RCT, Jan Erik Berdal, Lørenskog, Norway

 

Honorary lecture
16:50 – 17:40 Chair: Truls Leegaard
Diagnostics in a time of increasing antibiotic resistance, Arnfinn Sundsfjord, Tromsø, Norway

 

Welcome reception 

18.30 – 21.00 – Oslo City Hall

 

Friday 30. August

08.30 – 09:30 Pro et contra discussion: Gentamicin – does it have a future in the Nordics
Chairs: Jan Erik Berdal, Lørenskog, Norway and Per Espen Akselsen, Bergen, Norway and Barbara Holzknecht, Herlev, Denmark

(NordicAST): Gentamicin: which breakpoints do we have and why?

Pro: Jan Kristian Damås, Trondheim, Norway and Con: Håkan Hanberger, Linköping, Sweden

 

09.45 – 10:00 Coffee in the exibition

 

Symposium 4
10.00 – 11:30 Antimicrobial Stewardship in hospital practice in the Nordic countries
Chairs: Heidi Espvik, Lørenskog, Norway and Anders Johansson, Umeå, Sweden

Swedish strategies and experiences in AMS, Thomas Tängden

Norwegian strategies and experiences in AMS, Per Espen Akselsen

Nijmegen, the Netherlands: Basics, objectives and strategies of Antimicrobial Stewardship Programs: what is the evidence? Jeroen Schouten

 

11.30 – 12:30 Lunch

 

Poster Exibition with some selected poster presentations

12:30 – 14:00 Chair: Truls Leegaard, Lørenskog, Ahus and Ingrid Hoff, Skien, Norway

 

Gold sponsor: symposium by Shionogi

14:00 – 15:00 A patient centric approach to managing Carbapenemase Resistant Pseudomonas aeruginosa infections: the role of cefiderocol in overcoming 
resistance to beta-lactamase inhibitor combinations. Chair: Truls Leegaard, Lørenskog, Norway

What are the latest insights on Gram-negative bacteria susceptibility profiles and resistance, Ørjan Samuelsen, Tromsø, Norway

The PERSEUS Study: emerging evidence for cefiderocol in the treatment of CR P.aeruginosa infections, Alex Soriano, Barcelona, Spain

 

15.00 – 15:30 Coffee in the exhibition

 

Symposium 5

15.30 – 16:50 Infections in people who inject drugs
Chairs: Olav Dalgard, Lørenskog, Norway and Magnús Gottfreðsson, Reykjavik, Iceland

Chronic/recurrent infections and risk of renal amyloidosis, Ivar Eide, Lørenskog, Norway

Infective endocarditis, Magnus Rasmussen, Lund, Sweden

Skin and soft tissue infections (in people who inject drugs), Olav Dalgard, Lørenskog, Norway

 

16.50 – 17:00 Short break

 

Symposium 6

17.00 – 18:00 Viral hepatitis
Chairs: Olav Dalgard, Lørenskog, Norway and Magnús Gottfreðsson, Reykjavik, Iceland

Hepatitis B: Functional cure after stopping NUC therapy, Asgeir Johannessen, Tønsberg, Norway

Hepatitis C- New models of care, Kristian Malme, Lørenskog, Norway

 

18:15 – 20:15 City Walk: Thousand years in two hours – Oslo under your feet

 

Saturday 31. August

08:30 – 09:00 NSCMID General Assembly

 

Silver sponsor: symposium by AstraZeneca
09:00 – 09:30 Chairs: Ole Schmeltz Søgaard, Århus, Demark

COVID-19 is here to stay – who are still at risk even vaccinated, professor Asko Järvinen, Helsinki, Finland

 

09.30 – 09:40 Short break

 

Symposium 7

09.40 – 11:10 New vaccines
Chairs: Kirsten Gravningen, Lørenskog, Norway and and Asko Järvinen, Helsinki, Finland

New on the vaccine-horizon, Bolette Søborg, Copenhagen, Denmark

Covid-vaccines – past, present, future, Hanna Nohynek, Helsinki, Finland

RSV-vaccines – finally but how best to use them, Are Berg, Oslo, Norway

 

11.10 – 11:40 Coffee in the exhibition

 

Symposium 8

11.40 – 13:00 Effect of infection control measures
Chairs: Kirsten Gravningen, Lørenskog, Norway and Hanna Jarva, Helsinki, Finland

Effect of infection control measures in healthcare, Walter Zingg, Zürich, Switzerland

The implementation process and effect of Hand hygiene observations in Norwegian hospitals, Petter Elstrøm/Mette Fagernes, Oslo, Norway

The Norwegian toilet study: hospital toilets as a reservoir for nosocomial transmission of MDROs, Astri Lervik Larsen, Østfold Hospital Norway

 

13.00 – 14:00 Lunch

 

Invited young Scientists
14:00 – 15:20 Chairs: Truls Leegaard, Lørenskog, Norway and Lena Rós Ásmundsdóttir, Reykjavik, Iceland

Comparison of sensitive culture and Aspergillus PCR on Aspergillus galactomannan positive BAL fluids, Hanne Ellegaard Mikkelsen, Aalborg, Denmark

Carmen Chen, Helsinki, Finland: Antibiotic-resistant Acinetobacter baumannii can be killed by a combination of bacteriophages and complement

Is early antibiotic exposure associated with later childhood infections? Birta Bæringsdóttir, Reykjavik, Iceland

Duration, Dynamics, Microbiotaand Host-Associations of Klebsiella pneumoniae Species Complex Human Gastrointestinal Colonisation, Kenneth Lindstedt, Tromsø, Norway 

Bacterial 16S rRNA Identification – Nationwide Multicenter Study Evaluating Nanopore Sequencing, Sofia Brunet, Gothenburg, Sweden

 

15.30 – 16:00 Coffee in the exhibition

 

Symposium 9
16.00 – 17:30 Microbiology in the future
Chairs: Heidi Espvik, Lørenskog, Norway and Hans Linde Nielsen, Aalborg, Denmark

The Microbiology Laboratory in the future, Andreas Matussek, Oslo, Norway 

New sequencing techniques in diagnostic microbiology, Hege Vangstein Aamot, Lørenskog, Norway

Clinical/Medical Microbiologist in the future – What should they do? Antti Hakanen, Turku, Finland

 

19:00 – Conference dinner at The Hub

 

Sunday 1. September

Symposium 10

09.00 – 10:00 Infections related to migration and travel to the Nordics

Chairs: Kirsten Gravningen, Lørenskog, Norway and Ingrid Hoff, Skien, Norway

Carbapenemase Producing Organisms on the Rise: Unveiling the Epidemiology in Norway, Miriam Sare, Oslo, Norway

Tropical infectious diseases in the Nordics related to migration and travel, Kristine Mørch, Bergen, Norway

 

10.00 – 10:30 Coffee in the exhibition

 

Hot topics
10.30 – 12:00 Chairs: Truls Leegaard, Lørenskog, Norway and Annika Ljung, Gothenburg, Sweden 

Determinants of host immunity to infectious diseases, Trine Mogensen, Aarhus, Denmark

Oral versus iv antibiotic therapy, Nis Pedersen Jørgensen, Aarhus, Denmark

Treatment of hepatitis D, Soo Aleman, Stockholm, Sweden

 

12.00 NSCMID 2025
12:10 Take away lunch